Gut bacteria diversity, digestive health, probiotics, prebiotics, and the gut-brain axis
532 articles
Transplanting aged human gut microbiota into pigs dismantles intestinal tight junctions and reshapes plasma metabolites, revealing microbial drivers of age-related gut decline.
A molecule secreted by a human gut bacterium reduces visceral fat in mice, pointing to a new microbiome-based strategy for treating obesity.
Male and female mice diverge sharply in blood glucose control and gut diversity when aging or missing the Nrf2 antioxidant gene.
Children whose microbiome plateaus early face a threefold higher Type 1 diabetes risk, and host genetics further modify that relationship.
Dr. Chris Thompson breaks down gut hormones, GLP-1 drugs, metabolic health, and the real tools for lasting weight loss.
A multinational metagenomics study finds gut microbiome profiles improve hospitalization prediction in cirrhosis beyond clinical variables alone.
A new review maps how gut microbiota interact with estrogen, ovarian function, and brain signaling to drive perimenopausal syndrome.
Dr. Chris Thompson breaks down how the GI tract controls hunger, metabolism, and longevity — and which interventions actually work.
A clinician's guide to reading gut microbiome results honestly — how barrier failure becomes systemic inflammation, why fiber and fermented foods outrank every supplement on trial evidence, and which drug–microbiome interactions change prescribing.
A 'smoldering' molecular defect in intestinal cells persists even when IBD symptoms disappear, potentially driving future flare-ups.
Transplanting young gut microbiota into aged mice reduced neuronal injury and inflammation after subarachnoid hemorrhage, spotlighting the gut-brain axis as a therapeutic target.
Alamandine restores intestinal integrity, reshapes the microbiome, and blocks pro-inflammatory myelopoiesis in aged mice.
